Herman Waldmann Ph.D., FRCPath, MRCP, FRS, FMedSci
Co-Founder, Chairman of the Scientific Advisory Board and Director,Tolerx, Inc.
|Age||Total Calculated Compensation||This person is connected to 20 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Herman Waldmann, Ph.D., FRCPath, MRCP, FRS, FMedSci, is a Co-founder of Tolerx, Inc. Dr. Waldmann has been a Professor of Pathology, Head of the Sir William Dunn School of Pathology at the University of Oxford and Clinical Director of the Therapeutic Antibody Centre (TAC), University of Oxford since 1994. Prior to that, Dr. Waldmann was a professor at the University of Cambridge. He serves as Chairman of Scientific Advisory Board of Tolerx, Inc. Dr. Waldmann serves ...
300 Technology SquarePhone: 617-452-1300
Cambridge, Massachusetts 02139
Board Members Memberships*
Co-Founder, Chairman of the Scientific Advisory Board and Director
University of Cambridge
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.